Arrowhead Pharmaceuticals Inc.
Organization details
- Legal name
- Arrowhead Pharmaceuticals Inc.
- Former names
- Arrowhead Research Corp Interactive Group Inc Interactive Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Pasadena
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- ARWR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000879407
- EIN
- 46-0408024
- Wikidata ID
- Q113530745
Board of directors
-
Adeoye Y. Olukotun · DirectorSince 2023
-
Backer Marianne De · DirectorSince 2023
-
Christopher Richard Anzalone · Director · Chief Executive OfficerSince 2023
-
Douglas B. Given · DirectorSince 2023
-
Douglas S. Ingram · DirectorSince 2025
-
Hongbo Lu · DirectorSince 2024
-
Matthew Gregory Cohen · DirectorSince 2026
-
Mauro Ferrari · DirectorSince 2023
-
Michael S. Perry · DirectorSince 2023
-
Victoria Vakiener · DirectorSince 2023
-
William D. Waddill · DirectorSince 2023
Chief executives
Director election results
Annual meeting of March 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
90.3%
Board connections
5 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Annexon Inc. Same sectorvia William D. Waddill
-
Protagonist Therapeutics Inc. Same sectorvia William D. Waddill
-
Relay Therapeutics Inc. Same sectorvia Douglas S. Ingram
-
Sarepta Therapeutics Inc. Same sectorvia Douglas S. Ingram
-
Tonix Pharmaceuticals Holding Corp. Same sectorvia Adeoye Y. Olukotun
-
Vir Biotechnology Inc. Same sectorvia Backer Marianne De
-
Zenas BioPharma Inc. Same sectorvia Hongbo Lu
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $37,344,096
- 64 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Adeoye Y. Olukotun Director | Open-market sale | −2,000 | $86.96 | $173,920 |
| Aug 18, 2026 | Michael S. Perry Director | Open-market sale | −11,600 | $87.30 | $1,012,680 |
| Jun 15, 2026 | Matthew Gregory Cohen Director | Grant or award | +11,882 | — | — |
| May 12, 2026 | Hongbo Lu Director | Open-market sale | −2,970 | $76.88 | $228,334 |
| Apr 23, 2026 | Hamilton James C Officer (Chief Medical Officer) | Open-market sale | −10,000 | $75.00 | $750,000 |
| Apr 22, 2026 | Apel Daniel Joseph Officer (Chief Financial Officer) | Open-market sale | −3,208 | $70.11 | $224,913 |
| Apr 22, 2026 | Apel Daniel Joseph Officer (Chief Financial Officer) | Open-market sale | −1,157 | $70.45 | $81,511 |
| Apr 22, 2026 | Apel Daniel Joseph Officer (Chief Financial Officer) | Open-market sale | −8,730 | $71.92 | $627,862 |
| Mar 5, 2026 | Hamilton James C Officer (Chief Medical Officer) | Open-market sale | −10,000 | $64.19 | $641,900 |
| Jan 6, 2026 | Hamilton James C Officer (Chief Medical Officer) | Grant or award | +75,000 | — | — |
| Jan 6, 2026 | Apel Daniel Joseph Officer (Chief Financial Officer) | Grant or award | +75,000 | — | — |
| Jan 6, 2026 | O'Brien Patrick Officer (COO) | Gift | −540 | — | — |
| Jan 6, 2026 | O'Brien Patrick Officer (COO) | Gift | −540 | — | — |
| Jan 6, 2026 | O'Brien Patrick Officer (COO) | Gift | −540 | — | — |
| Jan 6, 2026 | O'Brien Patrick Officer (COO) | Gift | −440 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Arrowhead Pharmaceuticals Inc.
Who is the CEO of Arrowhead Pharmaceuticals Inc.?
Christopher Richard Anzalone is Arrowhead Pharmaceuticals Inc.'s Chief Executive Officer.
How many directors are on Arrowhead Pharmaceuticals Inc.'s board?
Arrowhead Pharmaceuticals Inc.'s board has 11 directors: Adeoye Y. Olukotun, Backer Marianne De, Christopher Richard Anzalone, Douglas B. Given, Douglas S. Ingram, Hongbo Lu, Matthew Gregory Cohen, Mauro Ferrari, Michael S. Perry, Victoria Vakiener and 1 other.
Are Arrowhead Pharmaceuticals Inc. insiders buying or selling shares?
Over the last 12 months, Arrowhead Pharmaceuticals Inc. insiders made no open-market purchases and sold $37.3 million of shares in 64 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="arrowhead-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.